Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  66 results for ""BNT162 Vaccine""

Your Filters

Subject : antibody formation Subject : covid-19 Subject : emotional engagement Geographic : japan
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan.

  • Authors : Kageyama T; Department of Allergy and Clinical Immunology, Graduate School of Medicine, Japan.; Ikeda K

Subjects: Antibody Formation* ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Health Personnel*

  • Source: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2021 Dec; Vol. 27 (12), pp.Publisher: Elsevier Country of Publication: England NLM ID: 9516420 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1469-0691

Record details

Read More Add to Saved list
×
Academic Journal

SARS-CoV-2 spike protein antibody titers after the fourth dose of BNT162b2 vaccine among Japanese patients undergoing hemodialysis: a single-center study.

  • Authors : Watanabe S; Department of Urology, Jyoban Hospital of Tokiwa Foundation, Iwaki, Fukushima, Japan.; Sawano T

Subjects: Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/blood ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/immunology ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/immunology

  • Source: Frontiers in immunology [Front Immunol] 2024 Aug 21; Vol. 15, pp. 1412918. Date of Electronic Publication: 2024 Aug 21 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Cellular and humoral immune responses to COVID-19 booster vaccination in Japanese dialysis patients.

  • Authors : Yoshifuji A; Department of Nephrology, Tokyo Saiseikai Central Hospital, 1-4-17 Mita, Minato-Ku, Tokyo, 108-0073, Japan. .; Department of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan. .

Subjects: Renal Dialysis* ; COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: Clinical and experimental nephrology [Clin Exp Nephrol] 2024 Jul; Vol. 28 (7), pp. 674-682. Date of Electronic Publication: 2024 Mar 08.Publisher: Springer Country of Publication: Japan NLM ID: 9709923 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Effectiveness of BNT162b2 Against Infection, Symptomatic Infection, and Hospitalization Among Older Adults Aged ≥65 Years During the Delta Variant Predominance in Japan: The VENUS Study.

  • Authors : Mimura W; Section of Clinical Epidemiology, Department of Data Science, Center for Clinical Sciences, National Center for Global Health and Medicine.; Ishiguro C

Subjects: Hospitalization*/Hospitalization*/Hospitalization*/statistics & numerical data ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/epidemiology SARS-CoV-2 variants

  • Source: Journal of epidemiology [J Epidemiol] 2024 Jun 05; Vol. 34 (6), pp. 278-285. Date of Electronic Publication: 2024 Jan 31.Publisher: Japan Epidemiological Association Country of Publication: Japan NLM ID: 9607688

Record details

Read More Add to Saved list
×
Academic Journal

Effectiveness of BNT162b2 Vaccine Against Symptomatic SARS-CoV-2 Infection in Children Aged 5-11 Years in Japan During Omicron Variant Predominate Periods.

  • Authors : Hara M; Department of Preventive Medicine, Faculty of Medicine, Saga University.; Ohta Y

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage SARS-CoV-2 variants

  • Source: Journal of epidemiology [J Epidemiol] 2024 May 05; Vol. 34 (5), pp. 205-210. Date of Electronic Publication: 2023 Oct 31.Publisher: Japan Epidemiological Association Country of Publication: Japan NLM ID: 9607688

Record details

Read More Add to Saved list
×
Academic Journal

Febrile Reactions Associated with High IgG Antibody Titers after the Second and Third BNT162b2 Vaccinations in Japan.

  • Authors : Wakazono N; Department of Respiratory Medicine, Center for Respiratory Diseases, Japan Community Healthcare Organization Hokkaido Hospital, Japan.; Nagai K

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/adverse effects ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Fever*/Fever*/Fever*/chemically induced

  • Source: Japanese journal of infectious diseases [Jpn J Infect Dis] 2023 Sep 22; Vol. 76 (5), pp. 275-281. Date of Electronic Publication: 2023 Apr 28.Publisher: National Institute of Infectious Diseases Country of Publication: Japan NLM ID: 100893704 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Antibody response to third and fourth BNT162b2 mRNA booster vaccinations in healthcare workers in Tokyo, Japan.

  • Authors : Sanada T; Department of Microbiology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.; Honda T

Subjects: BNT162 Vaccine* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Humans

  • Source: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2023 Mar; Vol. 29 (3), pp. 339-346. Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9608375 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Adverse Reactions and Attitudes Toward the BNT162b2 COVID-19 Vaccine in Children 5 to 11 Years of Age in Japan.

  • Authors : Matsumoto N; Department of Epidemiology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University.; Shimizu J

Subjects: BNT162 Vaccine* ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects

  • Source: Journal of epidemiology [J Epidemiol] 2023 Feb 05; Vol. 33 (2), pp. 110-111. Date of Electronic Publication: 2022 Nov 30.Publisher: Japan Epidemiological Association Country of Publication: Japan NLM ID: 9607688

Record details

Read More Add to Saved list
×
Report

Humoral and cellular responses to the third COVID-19 BNT162b2 vaccine dose in research institute workers in Japan.

  • Authors : Nishikimi A; Biosafety Administration Division, Research Institute, National Center for Geriatrics and Gerontology, Aichi, Japan. Electronic address: .; Nakagawa T

Subjects: BNT162 Vaccine* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Humans

  • Source: The Journal of infection [J Infect] 2023 Feb; Vol. 86 (2), pp. e33-e35. Date of Electronic Publication: 2022 Oct 21.Publisher: W.B. Saunders Country of Publication: England NLM ID: 7908424 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Real-world evidence for the effectiveness and breakthrough of BNT162b2 mRNA COVID-19 vaccine at a medical center in Japan.

  • Authors : Naito T; Department of General Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Yan Y

Subjects: BNT162 Vaccine* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; COVID-19 Vaccines SARS-CoV-2 variants

  • Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 1-2. Date of Electronic Publication: 2021 Oct 06.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  66 results for ""BNT162 Vaccine""